<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>DSpace Собрание:</title>
    <link>http://dspace.zsmu.edu.ua/handle/123456789/238</link>
    <description />
    <pubDate>Tue, 12 May 2026 18:18:45 GMT</pubDate>
    <dc:date>2026-05-12T18:18:45Z</dc:date>
    <item>
      <title>Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction</title>
      <link>http://dspace.zsmu.edu.ua/handle/123456789/24969</link>
      <description>Название: Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction
Авторы: Berezin, A. E.; Kremzer, A. A.; Martovitskaya, Y. V.; Berezina, T. A.; Gromenko, E. A.; Кремзер, Олександр Олександрович
Аннотация: Background: Chronic heart failure (HF) remains a leading cause of cardiovascular (CV) mortality and morbidity&#xD;
worldwide. The aim of the study was to investigate whether the pattern of angiogenic endothelial progenitor&#xD;
cells (EPCs) and apoptotic endothelial cell-derived microparticles (EMPs) would be able to differentiate HF&#xD;
with reduced (HFrEF) and preserved (HFpEF) ejection fraction.&#xD;
Methods: One hundred sixty four chronic HF subjects met inclusion criteria. Patients with global left ventricular&#xD;
ejection fraction ≥50% were categorized as the HFpEF group (n = 79) and those with ≤45% as the HFrEF group&#xD;
(n = 85). Therefore, to compare the circulating levels of biological markers 35 control subjects without HF&#xD;
were included in the study. All control individuals were age- and sex-matched chronic HF patients. The serum&#xD;
level of biomarkers was measured at baseline. The flow cytometric technique was used for predictably&#xD;
distinguishing circulating cell subsets depending on expression of CD45, CD34, CD14, Tie-2, and CD309 antigens&#xD;
and determining endothelial cell-derived microparticles. CD31+/annexin V+ was defined as apoptotic endothelial&#xD;
cell-derived MPs, MPs labeled for CD105+ or CD62E+ were determined as MPs produced due to activation of&#xD;
endothelial cells.&#xD;
Results: In multivariate logistic regression model T2DM(R2=0.26; P=0.001), obesity (R2=0.22; P=0.001),&#xD;
previous MI (R2 = 0.17; P = 0.012), galectin-3 (R2 = 0.67; P = 0.012), CD31+/annexin V+ EMPs (R2 = 0.11;&#xD;
P = 0.001), NT-proBNP (R2 = 0.11; P = 0.046), CD14+CD309+ cells (R2 = 0.058; P = 0.001), and&#xD;
CD14+СD309+ Tie-2+ cells (R2 = 0.044; P = 0.028) were found as independent predictors of HFpEF. Using&#xD;
multivariate Cox-regression analysis adjusted etiology (previous myocardial infarction), cardiovascular risk&#xD;
factors (obesity, type 2 diabetes mellitus) we found that NT-proBNP (OR 1.08; 95% CI = 1.03–1.12; P =&#xD;
0.001) and CD31+/annexin V+ EMPs to CD14+CD309+ cell ratio (OR 1.06; 95% CI = 1.02–1.11; P = 0.02)&#xD;
were independent predictors for HFpEF.&#xD;
Conclusion: We found that CD31+/annexin V+ EMPs to CD14+CD309+ cell ratio added to NT-proBNP, clinical&#xD;
data, and cardiovascular risk factors has exhibited the best discriminate value and higher reliability to predict&#xD;
HFpEF compared with NT-proBNP and clinical data/cardiovascular risk factors alone.</description>
      <pubDate>Fri, 01 Jan 2016 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://dspace.zsmu.edu.ua/handle/123456789/24969</guid>
      <dc:date>2016-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Взаимосвязь между циркулирующим уровнем остеопротегерина и инсулинорезистетностью у больных с хронической сердечной недостаточностью ишемического генеза</title>
      <link>http://dspace.zsmu.edu.ua/handle/123456789/24923</link>
      <description>Название: Взаимосвязь между циркулирующим уровнем остеопротегерина и инсулинорезистетностью у больных с хронической сердечной недостаточностью ишемического генеза
Авторы: Кремзер, А. А.; Кремзер, Олександр Олександрович; Kremser, О. О.
Аннотация: Метою даного дослідження було&#xD;
встановити взаємозв’язок між циркулюючим рівнем остеопротегеріна (ОПГ&#xD;
) і інсулінорезістетністю у хворих з ХСН&#xD;
ішемічного генезу.&#xD;
У дослідженні взяли участь 300&#xD;
пацієнтів з документованою ішемічною&#xD;
хворобою серця і ХСН у віці від 48 до&#xD;
62 років. Резистентність до інсуліну&#xD;
верифікували за моделлю оцінки гомеостазу ( HOMA   IR ) . Оцінка внутрішньосерцевої кардіогемодинаміки&#xD;
здійснювалася за допомогою трансторакальной ехокардіографії за загальноприйнятим методом у В  режимі ехолокації , імпульсної і тканинної доплерографії . Зміст ОЗГ було виміряно за допомогою техніки ELISA на початку&#xD;
дослідження одноразово.&#xD;
Результати. Формування ІР у&#xD;
пацієнтів з ХСН ішемічного генезу у&#xD;
відсутності цукрового діабету 2 типу&#xD;
асоціюється з істотним підвищенням&#xD;
циркулюючого рівня ОПГ. Мультіваріантний логістичний аналіз дозволив&#xD;
встановити , що тільки рівень ОПГ (r =&#xD;
0,516; P = 0,002), швидкість глобальної&#xD;
поздовжньої деформації ЛШ (r = 0,462 ;&#xD;
P = 0,001 ) , швидкість глобальної деформації по колу (r = 0,401 ; P = 0,001 )&#xD;
і NT pro МНУП (r = 0,326; P = 0,001) незалежно асоціювалися з ІР. При цьому&#xD;
дискримінантний потенціал ОПГ в поєднанні зі швидкістю глобальної поздовжньої деформації ЛШ або з ФК ХСН достовірно не відрізняється від такого у&#xD;
ОПГ. The purpose of this study was to&#xD;
determine the relationship between&#xD;
circulating levels of osteoprotegerin&#xD;
(OPG) and insulin resistance in patients&#xD;
with ischemic chronic heart failure (CHF).&#xD;
The study involved 300 patients with&#xD;
documented coronary artery disease and&#xD;
heart failure at the age of 48 to 62 years.&#xD;
Insulin resistance verified by the&#xD;
homeostasis model assessment (HOMAIR). Evaluation of cardiac hemodynamics&#xD;
was performed using transthoracic&#xD;
echocardiography by the generally&#xD;
accepted in the B mode echolocation&#xD;
pulse and tissue Doppler imaging. OPG&#xD;
content was measured using the ELISA&#xD;
technique once at baseline.&#xD;
Results. Resistance for insulin in&#xD;
patients with ischemic CHF without type&#xD;
2 diabetes mellitus is associated with a&#xD;
significant increase in circulating levels&#xD;
of OPG. Multivariate logistic analysis&#xD;
revealed that only the level of OPG (r =&#xD;
0.516; P = 0.002), global longitudinal strain&#xD;
rate LV (r = 0.462; P = 0.001), the global&#xD;
circumference rate of LV (r = 0.401; P =&#xD;
0.001), and NT pro BNP (r = 0.326; P =&#xD;
0.001) were independently associated with&#xD;
TS. In this discriminant potential OPG&#xD;
combined with the speed of the global left&#xD;
ventricular longitudinal strain or CHF FC&#xD;
was not significantly different from that of&#xD;
OPG.</description>
      <pubDate>Wed, 01 Jan 2014 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://dspace.zsmu.edu.ua/handle/123456789/24923</guid>
      <dc:date>2014-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>The Association of Subclinical Hypothyroidism and Pattern of Circulating Endothelial-Derived Microparticles Among Chronic Heart Failure Patients</title>
      <link>http://dspace.zsmu.edu.ua/handle/123456789/24904</link>
      <description>Название: The Association of Subclinical Hypothyroidism and Pattern of Circulating Endothelial-Derived Microparticles Among Chronic Heart Failure Patients
Авторы: Berezin, A. E.; Kremzer, O. O.; Martovitskaya, Yu. V.; Samura, T. A.; Berezina, T. A.; Березін, О. Є.; Кремзер, Олександр Олександрович; Самура, Тетяна Олександрівна
Аннотация: Background: Subclinical hypothyroidism (SH) is diagnosed biochemically by the presence of normal serum free thyroxine concentration, in conjunction with an elevated serum thyroid-stimulating hormone level. Recent studies have demonstrated the frequent association between SH and cardiovascular diseases and risk factors.&#xD;
Objectives: To evaluate the impact of SH on patterns of circulating endothelial-derived microparticles, (EMPs) among chronic heart failure (CHF) patients&#xD;
Patients and Methods: This is a retrospective study involving a cohort of 388 patients with CHF. Fifty-three CHF subjects had SH and 335 patients were free from thyroid dysfunction. Circulating levels of N-terminal-pro brain natriuretic peptide (NT-proBNP), high-sensitivity C-reactive protein (hs-CRP), thyroid-stimulating hormone (TSH), total and free thyroxine (T4), and triiodothyronine (T3), and endothelial apoptotic microparticles (EMPs), were measured at baseline. SH was defined, according to contemporary clinical guidelines, as a biochemical state associated with an elevated serum TSH level of greater 10 μU/L and normal basal free T3 and T4 concentrations.&#xD;
Results: Circulating CD31+/annexin V+ EMPs were higher in patients with SH compared to those without SH. In contrast, activated CD62E+ EMP numbers were not significantly different between both patient cohorts. Using uni (bi) variate and multivariate age- and gender-adjusted regression analysis, we found several predictors that affected the increase of the CD31+/annexin V+ to CD62E+ ratio in the patient study population. The independent impact of TSH per 6.5 μU/L (odds ratio [OR] = 1.23, P = 0.001), SH (OR = 1.22, P = 0.001), NT-proBNP (OR = 1.19, P = 0.001), NYHA class (OR = 1.09, P = 0.001), hs-CRP per 4.50 mg/L (OR = 1.05, P = 0.001), dyslipidemia (OR = 1.06, P = 0.001), serum uric acid per 9.5 mmol/L (OR = 1.04, P = 0.022) on the increase in the CD31+/annexin V+ to CD62E+ ratio, was determined.&#xD;
Conclusions: We believe that the SH state in CHF patients may be associated with the impaired pattern of circulating EMPs, with the predominantly increased number of apoptotic-derived microparticles.</description>
      <pubDate>Thu, 01 Jan 2015 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://dspace.zsmu.edu.ua/handle/123456789/24904</guid>
      <dc:date>2015-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Dibenzoxazepine Anodic Determination and Removal on CuS Nanoparticles: A Theoretical Insight</title>
      <link>http://dspace.zsmu.edu.ua/handle/123456789/24872</link>
      <description>Название: Dibenzoxazepine Anodic Determination and Removal on CuS Nanoparticles: A Theoretical Insight
Авторы: Tkach, V. V.; Kushnir, M. V.; de Oliveira, S. C.; Biryuk, I. G.; Sykyrytska, T. B.; Ivanushko, Ya. G.; Yagodynets', P. I.; da Silva, A. O.; Derevianko, N. P.; Zavhorodnii, M. P.; Odyntsova, V. M.; Krasko, M. P.; Shevchenko, I. M.; Lavrinenko, V. M.; Yermak, O. T.; Niyazov, L. N.; Musayeva, D. M.; Kosimov Jabborova, O.; Sagdullayeva, G.; Sharipova, E.; Morozova, T. V.; Mudrak, O. V.; Garcia, J. R.; José Inácio Ferrão da Paiva Martins; Kormosh, Zh. O.; Grekova, A. V.; Burdina, Ia. F.; Lavrik, R. V.; Одинцова, Віра Миколаївна; Красько, Микола Петрович
Аннотация: For the first time, the electroanalytical system for the electrochemical determination and removal of dibenzoxazepine chemical warfare agent on CuS-modified anode has been given. Two oxidation scenarios, including the electropolymerization and N-oxidation, are possible for dibenzoxazepine. Either way, both dibenzoxazepine and its N-oxide will be removed from the environment towards the polymer phase. The analysis of the electroanalytical process using linear stability theory and bifurcation analysis confirms that the steady-state stability allows us to use this process for both electroanalytical and electrocatalytic purposes.</description>
      <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://dspace.zsmu.edu.ua/handle/123456789/24872</guid>
      <dc:date>2026-01-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

